The International Journal of Risk & Safety in Medicine
Patient Safety - Pharmacovigilance - Medical Law
ISSN: 0924-6479
Volume 23; 4 issues
Institutional subscription (print and online) for 2011: €573 / US$775 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: Last issue (volume 23:1) online on 14 March 2011
Next issue (volume 23:2) scheduled for June 2011

Aims and Scope
Editorial Board
Submission of Manuscripts

Download flyer for this journal

Editor
C.J. Van Boxtel
Gustav Mahlerplein 145
1082 MS Amsterdam
The Netherlands
Tel.: +31 20 6448009 (+ Fax)
E-mail: cvboxtel@upcmail.nl

Founding Editor
M.N.G. Dukes

Associate Editors
Patient Safety
C. Vincent
London
United Kingdom
E-mail: c.vincent@imperial.ac.uk


Pharmacovigilance
I.R. Edwards
Uppsala
Sweden
E-mail: ralph.edwards@who-umc.org


Medical Law
M.B. Kapp
Tallahassee, FL
USA
E-mail: marshall.kapp@med.fsu.edu

 
Editorial Board
D. Body, Medical Negligence M. Lindquist, Safety Science
P.R. Breggin, Psychiatry D.H. Marks, Internal Medicine, Microbiology
L.T.W. De Jong-Van Den Berg, Pharmacy P. Peters, Pregnancy
B.A.J.M. De Mol, Safety Science A.P. Shroff, FDA Issues
E. Ernst, Complementary Medicine D.W. Sigelman, Public Health Law
T. Hasegawa, Public Health T. Tijmstra, Health Sciences
E. Helsing, International Health J. Turner, Health Services
S.P. Kruszewski, Neuropsychiatry and Addiction Medicine R. Wears, Emergency Medicine, Patient Safety
N. Kshirsagar, Clinical Pharmacology R.McL. Wilson, Public Health, Patient Safety
M.K. Kulzhanov, Public Health F-D. Zeng, Pharmacoepidemiology
J. Labadie, Vaccine Safety Specialist L.E. Ziganshina, Clinical Pharmacology

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
The International Journal of Risk and Safety in Medicine is concerned with rendering the practice of medicine as safe as it can be; that involves promoting the highest possible quality of care, but also examining how those risks which are inevitable can be contained and managed. This is not exclusively a drugs journal. Recently it was decided to include in the subtitle of the journal three items to better indicate the scope of the journal, i.e. patient safety, pharmacovigilance and liability and the Editorial Board was adjusted accordingly. For each of these sections an Associate Editor was invited. We especially want to emphasize patient safety. Our journal wants to publish high quality interdisciplinary papers related to patient safety, not the ones for domain specialists. For quite some time we have also been devoting some pages in every issue to what we simply call WHO news. This affinity with WHO underlines both the International character of the journal and the subject matter we want to cover. Basic research, reports of clinical experience and overviews will all be considered for publication, but since major reviews of the literature are often written at the invitation of the Editorial Board it is generally advisable to consult with the Editor in advance. Submission of news items will be appreciated, as will be the contribution of letters on topics which have been dealt with in the journal.

Abstracted In
CAB Abstracts, CSA Illumina, e-psyche database, EBSCO database, Elsevier BIOBASE, Embase, EMCare, Global Health, Index Copernicus, Index Medicus, International Pharmaceutical Abstracts, MEDLINE, PsycINFO, PubMed, Risk Abstracts, SciVerse Scopus
Backvolumes
1-22

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019
E-mail: info@iospress.nl